News | April 17, 2007

Masimo Files for IPO of Up to $150M

April 18, 2007 - Masimo Corp. filed with the Securities and Exchange Commission for an initial public offering of up to $150 million in common stock. The Irvine, CA-based medical technology company makes noninvasive patient monitoring products.

The company didn't disclose how many shares will be offered, nor did it provide an estimated price range for the offering.

The company said it expects to use about $15 million to $20 million of the net proceeds from this offering in capital expenditures and deferred cost of sales, primarily representing the placement of equipment under long-term sensor purchase contracts, and about $7.5 million in miscellaneous capital purchases.

The company said it intends to use the remainder net proceeds for ongoing research and development, sales and marketing activities and increased costs associated with becoming a public company.

Piper Jaffray, Deutsche Bank Securities, Cowen and Co. and Thomas Weisel Partners LLC are listed as underwriters for the offering.

The company said it plans to list its stock on the Nasdaq Global Market, under the symbol of MASI.

For the year 2006, the company's net income increased to $181.6 million from 2005's $33.4 million. Its 2006 revenue more than doubled to $224 million from $108 million in 2005, according to the company's prospectus.

Related Content

News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
News | Image Guided Radiation Therapy (IGRT) | July 13, 2017
Elekta and Sunnybrook Health Sciences Centre have initiated installation of Elekta’s MR-linac, an investigational...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced...
News | Image Guided Radiation Therapy (IGRT) | May 24, 2017
The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as part of a clinical...
Mevion and medPhoton Bring Advanced Cone Beam CT Imaging to Proton Therapy
News | Proton Therapy | May 04, 2017
Mevion Medical Systems announced a strategic agreement with medPhoton GmbH to integrate ImagingRing, an innovative cone...
ViewRay, MRIdian Linac system, FDA 510k approval, MRI-guided radiation therapy
Technology | Image Guided Radiation Therapy (IGRT) | February 27, 2017
February 27, 2017 — ViewRay Inc. announced that the company received 510(k) clearance from the U.S.
Overlay Init